Provention Bio, Inc.
Customers
0
None disclosed
Suppliers
1
0 disclosed
Latest period
Dec 31, 2023
10-K filed 2025-03-20
Suppliers 1
Companies that disclose Provention Bio, Inc. as a major customer, as a share of their own revenue. 0 active, 1 lapsed.
| Company | % of their revenue | Est. $ from Provention Bio, Inc. | Period | Trend | Status | Source |
|---|---|---|---|---|---|---|
| MGNX MACROGENICS INC |
10% | $5.9M | FY 2023-12-31 | −33.0pp | Lapsed Last seen 2023-12-31 |
10-K 2025-03-20 |
The following table includes those counterparties that represent more than 10% of total revenue earned in the periods indicated:Year Ended December 31,202420232022Incyte Corporation (Incyte)76%53%26%McKesson Plasma & Biologics and McKesson Specialty Care Distribution LLC (McKesson)*12%*ASD Healthcare and Oncology Supply (ASD)*10%*Provention Bio, Inc. (Provention)*10%43%Zai Lab Limited (Zai Lab)**15% Provention Bio, Inc. (Provention) 10 % — % — % | ||||||
Unnamed major customers
Disclosed without names in the fiscal year ending 2022-12-31. Identities are not inferred.
Alerts are coming
Get an email when Provention Bio, Inc.'s disclosed suppliers or customers change. Join the list and we'll tell you when alerts launch. One email, no spam.